DOR BioPharma Announces Advances in Mucosal Vaccines for Botulinum Toxin (Business Wire via Yahoo! Finance)
MIAMI----April 7, 2006--DOR BioPharma, Inc. announced today the first successful evaluation in animal tests of a nasal, bivalent combination of its botulinum toxin vaccine, BT-VACC, addressing two of the most prevalent serotypes of botulinum toxin, types A and B.

Amarin Announces Preclinical Results of Miraxion in Neurodegenerative Diseases Highlighted in Two Poster Presentations (RedNova)
LONDON, April 7 /PRNewswire-FirstCall/ -- Amarin Corporation plc today announced that Professor Cai Song, M.D., Ph.D.

A Changing Prescription for Biotechnology (CNW Group via Yahoo! Finance)
Twenty years ago the first annual analysis on the biotechnology industry -- Biotech 86: At the Crossroads -- described an industry that was just 10 years into its development and comprised of around 700 companies concentrated in the San Francisco and Boston areas.